EzraBio
Ithaca
About EzraBio
EzraBio provides quick and easy RNA adenylation technology, enabling ribosome profiling without limitations. They offer rapid cDNA library construction. They offer streamlined services from sample preparation to deep sequencing.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $256.0K
- Last round: Grant (Apr 2022)
- Website: ezrabio.com
- Phone: [email protected]
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/ezrabio-192836 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.